Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Organisation › Details

Skyhawk Therapeutics (Group)

Skyhawk Therapeutics is committed to discovering, developing and commercializing therapies that use its novel SkySTAR™ (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) platform to build small molecule drugs that bring breakthrough treatments to patients. *

 

Period Start 2019-01-04 existent
Products Industry small-molecule drug
  Industry 2 SkySTAR™ technology platform (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA)
Person Person Haney, Bill (Skyhawk Therapeutics 201901 CEO + Co-Founder)
     
  Street 35 Gatehouse Drive
  City 02451 Waltham, MA
  Tel +1-617-858-0041
    Address record changed: 2019-03-19
     
Basic data Employees n. a.
     
    * Document for �About Section�: Biogen Inc.. (1/4/19). "Press Release: Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets". Cambridge, MA & Waltham, MA.
     
   
Record changed: 2019-03-19

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Skyhawk Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top